Access to the next wave of biologic therapies (Abatacept and Tocilizumab) for the treatment of rheumatoid arthritis in England and Wales: Addressing treatment outside the current NICE guidance

Patients in England and Wales with rheumatoid arthritis (RA) receive treatment from the National Health Service (NHS) with therapies approved by the European Medicines Agency (EMA), under guidance from the National Institute for Health and Clinical Excellence (NICE). This document overviews the curr...

Descripción completa

Detalles Bibliográficos
Autores principales: Chiu, Yee, Ostor, Andrew J. K., Hammond, Anthony, Sokoll, Katharina, Anderson, Marina, Buch, Maya, Ehrenstein, Michael R., Gordon, Patrick, Steer, Sophia, Bruce, Ian N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer-Verlag 2012
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3362712/
https://www.ncbi.nlm.nih.gov/pubmed/22271229
http://dx.doi.org/10.1007/s10067-011-1936-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3362712/
https://www.ncbi.nlm.nih.gov/pubmed/22271229
http://dx.doi.org/10.1007/s10067-011-1936-6

Ejemplares similares